As of 2025-07-05, the Relative Valuation of Aerie Pharmaceuticals Inc (AERI) is (14.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.25 USD, the upside of Aerie Pharmaceuticals Inc based on Relative Valuation is -195.0%.
The range of the Relative Valuation is (14.63) - (13.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 18.9x | 18.5x |
| Forward P/E multiples | 19.8x - 21.7x | 20.6x |
| Fair Price | (14.63) - (13.95) | (14.48) |
| Upside | -195.9% - -191.5% | -195.0% |
| Date | P/E |